Abiopharma

ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit With the Schall Law Firm

Shareholder Alert: The Ademi Firm investigates whether Generation Bio Co. is obtaining a Fair Price for its Public Shareholders

Study Finds CAVT Shortens Hospital Stay and May Ease Burden on Hospital Systems

Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace

GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders

Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

ResMed Inc. Daily Stock Update

Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025